Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Q&A: What do scientists need to learn next about blocking enzymes to treat disease?

Enzymes are the molecular machines that power life; they build and break down molecules, copy DNA, digest food, and drive virtually every chemical reaction in our cells. For decades, scientists have designed drugs to slow down or block enzymes, stopping infections or the growth of cancer by jamming these tiny machines. But what if tackling some diseases requires the opposite approach?

Speeding enzymes up, it turns out, is much harder than stopping them. Tarun Kapoor is the Pels Family Professor in Rockefeller’s Selma and Lawrence Ruben Laboratory of Chemistry and Cell Biology. Recently, he has shifted the focus of this lab to tackle the tricky question of how to make enzymes work faster.

Already, his lab has developed a chemical compound to speed up an enzyme that works too slowly in people with a rare form of neurodegeneration. The same approach could open new treatment possibilities for many other diseases where other enzymes have lost function, including some cancers and neurodegenerative disorders such as Alzheimer’s.

This is how I’m preparing for AI (and you can too)

As AI replaces traditional wage labor, individuals should prepare for an automated future by adapting their skills, investments, and lifestyle to focus on economic stability, personal growth, and self-directed living ## ## Questions to inspire discussion.

Capital Economy Participation.

A: Invest in dividend-producing ETFs for a hands-off approach to wealth building, as AI and robotics reduce labor demand and shift wealth distribution toward capital ownership rather than wages.

🏢 Q: What ownership structures should I explore beyond traditional employment?

A: Consider Employee Stock Ownership Plans (ESOPs) to become a part-owner of companies, but approach Decentralized Autonomous Organizations (DAOs) cautiously due to their high-risk nature despite offering ownership opportunities.

⚠️ Q: Should I rely on Bitcoin for income generation?

CES Reality Check: Are Humanoid Robots Getting Better or Just Flashier?

Here is the key idea of the video in a single sentence: Humanoid robots are rapidly advancing in design, capabilities, and functionality, but despite their impressive developments, they still face significant challenges and limitations that hinder their practical application and widespread adoption.

## Questions to inspire discussion.

Manis Glove Technology.

🖐️ Q: How does the Manis glove achieve accurate hand tracking? A: The glove tracks 25 degrees of freedom using inverse kinematics based on 6DOF per fingertip (position and orientation), enabling accurate motion capture even when fingertips are obscured.

🔌 Q: What hardware enables the Manis glove’s position tracking? A: The system uses transmitters at the base and receivers in fingertips to determine precise fingertip position relative to the transmitter, with simple calibration allowing different hand sizes as long as sensors stay in place.

📳 Q: How does the Manis glove provide haptic feedback? A: Haptic feedback at the PIP joints vibrates upon contact, enabling virtual world interaction and realistic surface contact simulation for teleoperation and clinical evaluations.

Abstract: This study has broad implications across multiple neurological conditions

Jian Hu & team use mouse models to show peroxisomes license myelin debris degradation in myeloid cells, which enables debris clearance and remyelination after myelin damage:

The figure shows TEM micrographs of phagocytes in which PEX5 loss (bottom panel) aggregates lipid droplets and crystal accumulation.


1Department of Cancer Biology, MD Anderson Cancer Center, Houston, Texas, USA.

2University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.

3University of Puerto Rico School of Medicine, San Juan, Puerto Rico.

T cells gain superior memory through new reprogramming method, boosting cancer-fighting abilities

Georgetown University’s Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a superior memory, thereby making them more effective in killing cancer cells.

The finding, published January 12, 2026, in Nature Immunology, amplifies a known strategy of blocking the cellular activity of PARP, an enzyme that detects DNA abnormalities in cells and repairs them.

“This opens the door to a new area of research in understanding how our immune system works, and as importantly, it opens the way for the development of new strategies for the treatment of cancer,” says Samir N. Khleif, MD, director of The Center for Advanced Immunotherapy Research and the director of Loop Immuno-Oncology Research Laboratory at Georgetown’s Lombardi.

/* */